These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30595446)

  • 1. Identification of novel azaindazole CCR1 antagonist clinical candidates.
    Harcken C; Kuzmich D; Cook B; Mao C; Disalvo D; Razavi H; Swinamer A; Liu P; Zhang Q; Kukulka A; Skow D; Patel M; Patel M; Fletcher K; Sherry T; Joseph D; Smith D; Canfield M; Souza D; Bogdanffy M; Berg K; Brown M
    Bioorg Med Chem Lett; 2019 Feb; 29(3):441-448. PubMed ID: 30595446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and optimization of pyrazole amides as antagonists of CCR1.
    Harcken C; Sarko C; Mao C; Lord J; Raudenbush B; Razavi H; Liu P; Swinamer A; Disalvo D; Lee T; Lin S; Kukulka A; Grbic H; Patel M; Patel M; Fletcher K; Joseph D; White D; Amodeo L; Berg K; Brown M; Thomson DS
    Bioorg Med Chem Lett; 2019 Feb; 29(3):435-440. PubMed ID: 30455146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [
    Elie J; Vercouillie J; Arlicot N; Lemaire L; Bidault R; Bodard S; Hosselet C; Deloye JB; Chalon S; Emond P; Guilloteau D; Buron F; Routier S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1-7. PubMed ID: 30362376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338.
    Carter PH; Hynes J
    Expert Opin Ther Pat; 2010 Nov; 20(11):1609-18. PubMed ID: 20858032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.
    Pennell AM; Aggen JB; Sen S; Chen W; Xu Y; Sullivan E; Li L; Greenman K; Charvat T; Hansen D; Dairaghi DJ; Wright JJ; Zhang P
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1228-31. PubMed ID: 23374868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
    Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel series of indazole-/indole-based glucagon receptor antagonists.
    Lin S; Zhang F; Jiang G; Qureshi SA; Yang X; Chicchi GG; Tota L; Bansal A; Brady E; Trujillo M; Salituro G; Miller C; Tata JR; Zhang BB; Parmee ER
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4143-7. PubMed ID: 26303893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Timén ÅS; Bergare J; Mussie T; Bergström L
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4026-30. PubMed ID: 23769642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of indazoles as inhibitors of Tpl2 kinase.
    Hu Y; Cole D; Denny RA; Anderson DR; Ipek M; Ni Y; Wang X; Thaisrivongs S; Chamberlain T; Hall JP; Liu J; Luong M; Lin LL; Telliez JB; Gopalsamy A
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4758-61. PubMed ID: 21742493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold.
    Liu J; Peng X; Dai Y; Zhang W; Ren S; Ai J; Geng M; Li Y
    Org Biomol Chem; 2015 Jul; 13(28):7643-54. PubMed ID: 26080733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel series of human CCR1 antagonists.
    Xie YF; Sircar I; Lake K; Komandla M; Ligsay K; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Sakurai N; Barbosa M; Jack R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2215-21. PubMed ID: 18329267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors.
    Zhang X; Song F; Kuo GH; Xiang A; Gibbs AC; Abad MC; Sun W; Kuo LC; Sui Z
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4762-7. PubMed ID: 21767952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of BMS-457, a potent and selective CCR1 antagonist.
    Gardner DS; Santella JB; Duncia JV; Carter PH; Dhar TG; Wu H; Guo W; Cavallaro C; Van Kirk K; Yarde M; Briceno SW; Grafstrom RR; Liu R; Patel SR; Tebben AJ; Camac D; Khan J; Watson A; Yang G; Rose A; Foster WR; Cvijic ME; Davies P; Hynes J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3833-40. PubMed ID: 23707259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653.
    Norman P
    Expert Opin Ther Pat; 2009 Nov; 19(11):1629-33. PubMed ID: 19586423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.
    McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR1 and CCR2 antagonists.
    Zimmermann HW; Sterzer V; Sahin H
    Curr Top Med Chem; 2014; 14(13):1539-52. PubMed ID: 25159163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR1 antagonists.
    Cheng JF; Jack R
    Mol Divers; 2008 Feb; 12(1):17-23. PubMed ID: 18560988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPARγ agonists.
    Lamotte Y; Faucher N; Sançon J; Pineau O; Sautet S; Fouchet MH; Beneton V; Tousaint JJ; Saintillan Y; Ancellin N; Nicodeme E; Grillot D; Martres P
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1098-103. PubMed ID: 24462665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
    Zhang X; Hufnagel H; Hou C; Opas E; McKenney S; Crysler C; O'Neill J; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6042-8. PubMed ID: 21917454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and structure activity relationships of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Ivanova S; Bergare J; Mensonides-Harsema M; Cooper ME
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3500-4. PubMed ID: 23659855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.